phase readout
saveNCT01753557: Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C
COMPLETEDupdated 9d ago
community read0 votes
Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Chronic Hepatitis C (CHC)
view source ↗
comments(0)
5-min edit window · permanent after that